Zacharakis G, Almasoud A. Using of artificial intelligence: Current and future applications in colorectal cancer screening. World J Gastroenterol 2022; 28(24): 2778-2781 [PMID: 35979167 DOI: 10.3748/wjg.v28.i24.2778]
Corresponding Author of This Article
Georgios Zacharakis, BSc, MSc, PhD, Professor, Division of Gastroenterology, Department of Internal Medicine, College of Medicine, Prince Sattam bin Abdulaziz University Hospital, Arrayan, Al Kharj 16277, Saudi Arabia. g.zacharakis@psau.edu.sa
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Letter to the Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Jun 28, 2022; 28(24): 2778-2781 Published online Jun 28, 2022. doi: 10.3748/wjg.v28.i24.2778
Using of artificial intelligence: Current and future applications in colorectal cancer screening
Georgios Zacharakis, Abdulaziz Almasoud
Georgios Zacharakis, Division of Gastroenterology, Department of Internal Medicine, College of Medicine, Prince Sattam bin Abdulaziz University Hospital, Al Kharj 16277, Saudi Arabia
Abdulaziz Almasoud, Department of Gastroenterology and Hepatology, Prince Sultan Military Medical City, Riyadh 12233, Saudi Arabia
Author contributions: Zacharakis G and Almasoud A designed and performed the research and analyzed the data; Zacharakis G wrote the letter; Almasoud A revised the letter.
Conflict-of-interest statement: All authors declare no competing interests.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Georgios Zacharakis, BSc, MSc, PhD, Professor, Division of Gastroenterology, Department of Internal Medicine, College of Medicine, Prince Sattam bin Abdulaziz University Hospital, Arrayan, Al Kharj 16277, Saudi Arabia. g.zacharakis@psau.edu.sa
Received: March 23, 2022 Peer-review started: March 23, 2022 First decision: April 25, 2022 Revised: April 26, 2022 Accepted: June 13, 2022 Article in press: June 13, 2022 Published online: June 28, 2022 Processing time: 87 Days and 2.4 Hours
Abstract
Significant developments in colorectal cancer screening are underway and include new screening guidelines that incorporate considerations for patients aged 45 years, with unique features and new techniques at the forefront of screening. One of these new techniques is artificial intelligence which can increase adenoma detection rate and reduce the prevalence of colonic neoplasia.
Core Tip: Artificial intelligence (AI) is an integral part of endoscopy and health care in colorectal cancer screening because it has been shown to increase adenoma detection rates and reduce the prevalence of colonic neoplasia. It will soon provide an “optical biopsy” of polyps, assisting advanced therapeutic endoscopy-resection and ‘discard– no pathology present. ’Innovations in AI have changed and improved the lives of gastroenterologists by examining quality monitoring via a single integrated system. The only boundaries of AI are clinical research trials and reimbursement.
